中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
6期
95-96,121
,共3页
郑春昌%谭荣强%丁琼%周家承%郑诚
鄭春昌%譚榮彊%丁瓊%週傢承%鄭誠
정춘창%담영강%정경%주가승%정성
泪囊鼻腔吻合术%曲安奈德%复发率
淚囊鼻腔吻閤術%麯安奈德%複髮率
루낭비강문합술%곡안내덕%복발솔
Dacryocystorhinostomy%Cu ann ned%Recurrence rate
目的:探讨曲安奈德在泪囊鼻腔吻合术后降低复发率的作用。方法将本院88例慢性泪囊炎患者根据入院先后顺序随机分成对照组和观察组,对照组单纯行泪囊鼻腔吻合术,观察组患者行泪囊鼻腔吻合术时应用曲安奈德和肾上腺素混合液鼻黏膜注射,术后随访6~12个月,比较两组的临床总有效率及随访后的复发率。结果两组的临床总有效率比较无统计学差异(P>0.05),随访6~12月后对照组患者复发率明显高于观察组(P<0.05)。结论泪囊鼻腔吻合术中应用曲安奈德和肾上腺素混合液,增加了手术成功率、降低了手术难度、缩短了手术时间,具有疗效好,复发率低的特点,临床建议推广应用。
目的:探討麯安奈德在淚囊鼻腔吻閤術後降低複髮率的作用。方法將本院88例慢性淚囊炎患者根據入院先後順序隨機分成對照組和觀察組,對照組單純行淚囊鼻腔吻閤術,觀察組患者行淚囊鼻腔吻閤術時應用麯安奈德和腎上腺素混閤液鼻黏膜註射,術後隨訪6~12箇月,比較兩組的臨床總有效率及隨訪後的複髮率。結果兩組的臨床總有效率比較無統計學差異(P>0.05),隨訪6~12月後對照組患者複髮率明顯高于觀察組(P<0.05)。結論淚囊鼻腔吻閤術中應用麯安奈德和腎上腺素混閤液,增加瞭手術成功率、降低瞭手術難度、縮短瞭手術時間,具有療效好,複髮率低的特點,臨床建議推廣應用。
목적:탐토곡안내덕재루낭비강문합술후강저복발솔적작용。방법장본원88례만성루낭염환자근거입원선후순서수궤분성대조조화관찰조,대조조단순행루낭비강문합술,관찰조환자행루낭비강문합술시응용곡안내덕화신상선소혼합액비점막주사,술후수방6~12개월,비교량조적림상총유효솔급수방후적복발솔。결과량조적림상총유효솔비교무통계학차이(P>0.05),수방6~12월후대조조환자복발솔명현고우관찰조(P<0.05)。결론루낭비강문합술중응용곡안내덕화신상선소혼합액,증가료수술성공솔、강저료수술난도、축단료수술시간,구유료효호,복발솔저적특점,림상건의추엄응용。
Objective To investigate the role of cu ann ned in the relapse rate after dacryocystorhinostomy. Methods 88 cases of chronic dacryocystitis patients were randomLy divided into control group and observation group, the control group only underwent dacryocystorhinostomy, Cu Ann Ned and epinephrine mixed solution nasal mucosal injection patients in the observation group underwent dacryocystorhinostomy,patients were followed up for 6 to 12 months,the clinical comparison of two group's total efficiency and follow-up recurrence rate. Results The clinical effective rates of two groups showed no statistical difference (P>0.05), and were followed up for 6-12 months after the recurrence rate was higher than that of control group patients in observation group (P < 0.05). Conclusion The application of cu ann ned and epinephrine mixed solution dacryocystorhinostomy,increase the success rate of the operation,reduce the operation difficulty,shortens the operation time,has good curative effect,low recurrence rate characteristics,It's the use of clinical recommendations to promote.